| |
| |
| Exchange: |
N/A |
| Security
Type: |
Common |
| Shares
Out: |
19,370,000 |
| Market
Cap: |
776.74(K) |
| Last
Volume: |
0 |
Avg
Vol: |
0 |
| 52
Week Range: |
$0.0401 - $1.8 |
|
| Level
I Sector: |
N/A |
| Level
II Sector: |
N/A |
| Level
III Sector: |
N/A |
|
Member Indexes:
|
Rankings:
|
|
| Insider 3 Months : - |
| Insider 6 Months : - |
| Insider 3/6 Months : - |
|
| Guru Rank Number : - |
| Guru Rank Value : - |
| Guru Occurances : - |
|
|
|
|
|
| |
|
Company Profile Aravive is a clinical-stage biopharmaceutical company developing treatments designed to halt the progression of diseases, including cancer and fibrosis. Co.'s primary product candidate, batiraxcept, is a decoy protein that targets the GAS6-AXL signaling pathway. By capturing serum GAS6, batiraxcept starves the AXL pathway of its signal, potentially halting the biological programming that promotes disease progression. AXL receptor signaling plays a role in multiple types of malignancies by promoting metastasis, cancer cell survival, resistance to treatments, and immune suppression.
|
|
|
D/I:
|
|
|
D
is for direct shares.
I is
for indirect shares.
D/I
refers to the Direct or Indirect
shares traded vs. held. |
|
|
|
Forms:
|
|
|
A
Form 4 is a form filed
by an insider to indicate a change
in ownership.
A Form
3 is a form filed by
an insider to indicate an
initial ownership of a security. |
|
|
|
3m +/-:
|
|
|
|
This
represents the company's 3 month
price change. The initial price
is based on the closing price
of the stock on the day the transaction
took place. Purchases & sales
are viewed as long & short
positions respectively.
|
|
|
|
Actions:
|
|
|
| B |
Buy |
| S |
Sell |
| OE |
Option
Exercised |
| A |
Acquired |
| D |
Disposed |
| AB |
Automatic
Buy |
| AS |
Automatic
Sell |
| IO |
Initial
Ownership |
|
|
|
|
Download:
|
|
|
Download only Transactions
Forms. (Default)
Download
only Summary Infomation.
Download
both Transactions and Summary Data
|
|
|
|
|
| |
| |
Summary (Direct Transactions Only)  |
3 Months |
6 Months |
12 Months |
24 Months |
| Total Shares Bought |
0 |
0 |
0 |
0 |
| Total Buy Value |
$0 |
$0 |
$0 |
$0 |
| Total People Bought |
0 |
0 |
0 |
0 |
| Total Buy Transactions |
0 |
0 |
0 |
0 |
| Total Shares Sold |
0 |
0 |
0 |
0 |
| Total Sell Value |
$0 |
$0 |
$0 |
$0 |
| Total People Sold |
0 |
0 |
0 |
0 |
| Total Sell Transactions |
0 |
0 |
0 |
0 |
| End Date |
2024-02-11 |
2023-11-10 |
2023-05-12 |
2022-05-12 |
|
| Filer's Name |
Relation Title |
Off-Dir-10% |
Tran. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
  Sun Anthony Y |
Director |
– • – |
2016-05-18 |
4 |
A |
$0.00 |
$0 |
D/D |
4,625 |
9,200 |
|
- |
|
| Varian John |
Director |
– • – |
2016-05-18 |
4 |
A |
$0.00 |
$0 |
D/D |
4,625 |
9,200 |
|
- |
|
| Westberg Paul |
Sr. VP, Business Development |
• – – |
2016-04-21 |
4 |
S |
$9.68 |
$13,842 |
D/D |
(1,430) |
35,686 |
|
- |
|
| Brumm Joshua T |
Chief Financial Officer |
• – – |
2016-01-28 |
4 |
A |
$0.00 |
$0 |
D/D |
26,000 |
61,548 |
|
- |
|
| Shepard Jay |
President and CEO |
• • – |
2016-01-28 |
4 |
A |
$0.00 |
$0 |
D/D |
64,800 |
160,800 |
|
- |
|
| Westberg Paul |
Sr. VP, Business Development |
• – – |
2016-01-28 |
4 |
A |
$0.00 |
$0 |
D/D |
16,900 |
37,116 |
|
- |
|
| Ward Shane |
SVP, Legal and Compliance |
• – – |
2016-01-28 |
4 |
A |
$0.00 |
$0 |
D/D |
13,000 |
14,265 |
|
- |
|
| Westberg Paul |
Sr. VP, Business Development |
• – – |
2015-12-30 |
4 |
S |
$12.44 |
$4,502 |
D/D |
(362) |
20,216 |
|
- |
|
| Brumm Joshua T |
Chief Financial Officer |
• – – |
2015-12-30 |
4 |
S |
$12.44 |
$12,312 |
D/D |
(990) |
35,548 |
|
- |
|
| Brumm Joshua T |
Chief Financial Officer |
• – – |
2015-11-12 |
4 |
B |
$9.99 |
$24,975 |
D/D |
2,500 |
36,538 |
2.74 |
- |
|
| Greer R Scott |
Director |
– • – |
2015-11-11 |
4 |
B |
$10.15 |
$101,692 |
D/D |
10,000 |
25,075 |
2.39 |
- |
|
| Westberg Paul |
Sr. VP, Business Development |
• – – |
2015-08-04 |
4 |
AS |
$18.25 |
$43,840 |
D/D |
(2,400) |
20,578 |
|
- |
|
| Westberg Paul |
Sr. VP, Business Development |
• – – |
2015-08-04 |
4 |
OE |
$1.27 |
$3,036 |
D/D |
2,400 |
22,978 |
|
- |
|
| Westberg Paul |
Sr. VP, Business Development |
• – – |
2015-07-06 |
4 |
AS |
$15.00 |
$36,000 |
D/D |
(2,400) |
20,578 |
|
- |
|
| Westberg Paul |
Sr. VP, Business Development |
• – – |
2015-07-06 |
4 |
OE |
$1.27 |
$3,036 |
D/D |
2,400 |
22,978 |
|
- |
|
| Malik Shahzad |
Director |
– • • |
2015-06-29 |
4 |
A |
$0.00 |
$0 |
D/D |
4,575 |
4,575 |
|
- |
|
| Varian John |
Director |
– • – |
2015-06-29 |
4 |
A |
$0.00 |
$0 |
D/D |
4,575 |
4,575 |
|
- |
|
| Sun Anthony Y |
Director |
– • – |
2015-06-29 |
4 |
A |
$0.00 |
$0 |
D/D |
4,575 |
4,575 |
|
- |
|
| Akkaraju Srinivas |
Director |
– • – |
2015-06-29 |
4 |
A |
$0.00 |
$0 |
D/D |
4,575 |
4,575 |
|
- |
|
| Jennings Edmon R |
Director |
– • – |
2015-06-29 |
4 |
A |
$0.00 |
$0 |
D/D |
4,575 |
4,575 |
|
- |
|
| Greer R Scott |
Director |
– • – |
2015-06-29 |
4 |
A |
$0.00 |
$0 |
D/D |
4,575 |
15,075 |
|
- |
|
| Westberg Paul |
Sr. VP, Business Development |
• – – |
2015-06-11 |
4 |
D |
$17.28 |
$36,189 |
D/D |
(1,909) |
20,578 |
|
- |
|
| Brumm Joshua T |
Chief Financial Officer |
• – – |
2015-06-11 |
4 |
D |
$17.28 |
$48,078 |
D/D |
(2,597) |
34,038 |
|
- |
|
| Westberg Paul |
Sr. VP, Business Development |
• – – |
2015-06-03 |
4 |
AS |
$16.73 |
$40,142 |
D/D |
(2,400) |
22,487 |
|
- |
|
| Westberg Paul |
Sr. VP, Business Development |
• – – |
2015-06-03 |
4 |
OE |
$1.27 |
$3,036 |
D/D |
2,400 |
24,887 |
|
- |
|
258 Records found
|
|
Page 8 of 11 |
|
|
